Related Experiment Video
Updated: Jun 25, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
Published on: August 31, 2013
Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters
AnneMarie C Brescia1, Carlos D Rose, Paul T Fawcett
1Division of Rheumatology, AI duPont Hospital for Children, Wilmington, DE 19803, USA. abrescia@nemours.org
Insights
Many children with Lyme arthritis (LA) experience prolonged synovitis. This study found no predictors for disease duration in pediatric LA patients, indicating treatment delay, age, or seroreactivity do not influence recovery time.
Area of Science:
- Pediatric Rheumatology
- Infectious Diseases
- Clinical Medicine
Background:
- Lyme arthritis (LA) can persist in 10% of patients despite antibiotic treatment.
- Understanding the natural history and predictors of prolonged pediatric LA is crucial for effective management.
Purpose of the Study:
- To identify predictors of prolonged disease in pediatric Lyme arthritis.
- To further define the natural history of Lyme arthritis in children.
Main Methods:
- Retrospective review of medical records for 94 pediatric patients meeting CDC criteria for Lyme disease.
- Classification of patients based on the duration of synovitis.
- Statistical analysis using SPSS, including Pearson correlation, parametric, and nonparametric tests, linear and logistic regression.
Main Results:
- 39% of pediatric LA patients required over 6 months for synovitis resolution; 13% required over 12 months.
- No significant correlation was found between pre-treatment symptom duration and synovitis duration.
- No significant differences in age, antinuclear antibody positivity, ELISA titer, or Western blot reactivity were identified between groups.
- Linear and logistic regression analyses did not reveal any predictors for disease duration.
Conclusions:
- Approximately one-third of pediatric Lyme arthritis cases experience prolonged synovitis lasting over 6 months.
- Disease duration in pediatric LA is not associated with delayed treatment, patient age, or serological reactivity.
Abstract:
Ten percent of Lyme arthritis (LA) patients have continued synovitis despite antimicrobial therapy. The current study was designed to (1) investigate predictors of prolonged disease and (2) further define natural history of pediatric LA. Medical records of 94 children fulfilling Centers for Disease Control criteria for Lyme disease were reviewed, classified into groups according to duration of synovitis, and SPSS statistical software was used for analysis. Thirty-nine percent required >6 months and 13% required >12 months to resolve LA. Pearson correlation between duration of symptoms of LA pretreatment and duration of synovitis was not significant. When patients were stratified by group, no differences were found for age, antinuclear antibodies positivity, enzyme-linked immunosorbent assay titer, or reactivity of Western blot using parametric and nonparametric tests. Linear and logistic regression showed no predictors of disease duration. One third of pediatric LA patients require >6 months to resolve synovitis. Duration is not associated with delay in treatment, age, or seroreactivity.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Pyelonephritis II: Diagnostic Studies and Management
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Bacterial Meningitis II: Pathophysiology